Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Safeguard Scientifics SFE -- Ignore unavailable to you. Want to Upgrade?

To: Rob Palmer who wrote (2876)	5/19/1999 1:13:00 PM
From: michael r potter	Read Replies (4) \| Respond to of 4467

-OT- Possible trading buy. Pfizer PFE $112. Down from $150. Not cheap at 37 X "00 est. with app. 20% growth, but drug companies. because of sterling balance sheets and assured growth, seldom trade cheap. Pfizer is considered the cream of the crop, and an aggressive company. Should be a lot of support around $110-$112. Could use a $108 stop if trading. Chart not what I like to see, but is quite oversold. This is one that won't be down 30%-50% overnight because they missed an earnings #. Very long term uptrend, but every rare dip in that uptrend has been a buying opportunity, this appears to be one. Won't be a Southwest Security SWS type performance or SFE, but worth looking at for a possible trade or anyone looking for a real quality holding to put away for years and take advantage of the aging demographics and their [our] need for Viagra- oops, I mean drugs in general. Also, drugs are increasingly being used as the treatment of choice to save costs vs. other more invasive and expensive procedures. Mike